Treatment with Soliris (eculizumab) substantially reduces the risk and frequency of relapses in adults with neuromyelitis optica spectrum disorder (NMOSD) who test positive for antibodies against the aquaporin-4 (AQP4) protein. That’s according to a systematic review of published studies reporting results from clinical trials testing Soliris in this…
Discussion
If I take a minute to pause, I find myself in disbelief when I think about everything I’ve endured with neuromyelitis optica spectrum disorder (NMOSD). It’s as if all those difficult moments are pieced together as flashbacks that make up a terrifying mind movie, one I never auditioned for,…
Discussion
People with neuromyelitis optica spectrum disorder (NMOSD) report a greater burden of sleep problems and, when objectively monitored, spend more time in bed and sleeping than healthy people, according to a small study from Thailand. Data from 24 adults with NMOSD and self-reactive antibodies against the aquaporin-4 (AQP4) protein…
NMOSD is a progressive autoimmune disease where the immune system mistakenly attacks nerve cells, affecting the nervous system. Learn more about the disease here.
Scientists do not know the exact underlying cause of NMOSD. Self-reactive antibodies that target AQP4 are known to play a major role. Learn more about what causes the disease here.
When the disease affects the optic nerve (optic neuritis), it can result in pain inside the eye and possibly blurry vision or vision loss. Learn more about the symptoms of the disease here.
Get regular updates to your inbox.
